KTS is resulted from abnormal PI3K-AKT‐mTOR pathway activation, [22, 27] while PWS frequently harbors somatic activating mutations in the RAS-RAF-MAPK pathway [28]. The gene discussed is AKT1; the disease is angioosteohypertrophic syndrome.